Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome. 2017

Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University Shanghai, China.

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in women. Gut microbiota has been implicated to play a critical role in metabolic diseases and may modulate the secretion of mediators of the brain-gut axis. Interaction between gut microbiota and the endocrine and biochemical disturbances in PCOS still remains elusive. Here, we showed an altered gut microbiota significantly correlated with PCOS phenotype. There were 33 patients with PCOS (non-obese PCOS individuals, PN, n = 12; obese PCOS individuals, PO, n = 21) as well as 15 control subjects (non-obese control individuals, CN, n = 9; obese control individuals, CO, n = 6) enrolled in our study. The plasma levels of serotonin, ghrelin, and peptide YY (PYY) were significantly decreased in patients with PCOS compared with controls, and have a significantly negative correlation with waist circumference and testosterone. Sequencing of the V3-V4 region of the 16S rRNA gene in fecal samples revealed the substantial differences of gut microbial species between the PCOS and non-obese controls. Bacterial species were clustered into 23 co-abundance groups (CAGs) based on the SparCC correlation coefficients of their relative abundance. The CAGs increased in PCOS, including the bacteria belonging to Bacteroides, Escherichia/Shigella and Streptococcus, were negatively correlated with ghrelin, and positively correlated with testosterone and BMI. Furthermore, the CAGs that were decreased in PCOS, including the bacteria from Akkermansia and Ruminococcaceae, showed opposite relationship with body-weight, sex-hormone, and brain-gut peptides. In conclusion, gut microbial dysbiosis in women with PCOS is associated with the disease phenotypes.

UI MeSH Term Description Entries

Related Publications

Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
January 2023, Frontiers in cellular and infection microbiology,
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
November 2020, Canadian journal of physiology and pharmacology,
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
December 2022, Life (Basel, Switzerland),
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
January 2016, PloS one,
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
May 2024, BMC microbiology,
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
January 2022, Reproductive sciences (Thousand Oaks, Calif.),
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
June 2022, International immunopharmacology,
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
January 2020, Journal of the American College of Nutrition,
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
April 2021, Pediatric obesity,
Rui Liu, and Chenhong Zhang, and Yu Shi, and Feng Zhang, and Linxia Li, and Xuejiao Wang, and Yunxia Ling, and Huaqing Fu, and Weiping Dong, and Jian Shen, and Andrew Reeves, and Andrew S Greenberg, and Liping Zhao, and Yongde Peng, and Xiaoying Ding
August 2021, Journal of endocrinological investigation,
Copied contents to your clipboard!